QNTM (Quantum BioPharma Ltd) Earnings per share growth rate in current year
Quantum BioPharma Ltd (QNTM) annual earnings per share dynamics are based on asset restructuring and natural molecule testing, with the current value equal to 0.00. Development efficiency is increasing through the implementation of AI and robotic bio-screening. However, the lack of stable revenue and cannabis market volatility create serious financial threats, exacerbating the instability of the company's small-cap status.
Financial and market metric breakdowns for Quantum BioPharma Ltd (QNTM)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
Total Debt to Capital Quantum BioPharma Ltd|QNTM - Long-Term Debt to Capital|Short-Term Debt to Capital quantumbiopharma.com|QNTM - Company Debts|Debt to Book Value Ratio Quantum BioPharma Corp|QNTM - Company Long-Term Liabilities|Amount of Current Liabilities Quantum BioPharma|Quick Ratio quantumbiopharma.com
- net income and valuation multiples indicators:
QNTM - Company Net Income|Future Profit Quantum BioPharma Ltd|QNTM - Price to Earnings Ratio|Future Price to Earnings Multiple Quantum BioPharma Corp|QNTM - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Quantum BioPharma Corp|QNTM - Operating profit EBITDA|Net earnings per share for the last four quarters Quantum BioPharma|QNTM - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months quantumbiopharma.com|QNTM - Earnings per share growth in current year|Net earnings per share change forecast for next year Quantum BioPharma Ltd
Basic company analysis:Quantum BioPharma Ltd.
To protect capital amid market volatility, it is critical for investors to assess the stability of business returns. This indicator measures the annual percentage change in net profit per share, reflecting the growth rate of real earnings. By analyzing the EPS trajectory compared to the previous year, one can distinguish systemic development from random spikes. For Quantum BioPharma Ltd (QNTM), this allows for an assessment of the monetization efficiency of AI developments and grants. A positive trend would confirm the sustainability of the model for discovering new drug formulas.
Key competitors
Haleon PLC - Earnings per share increase in current year|KVUE (Kenvue Corp) - Earnings growth in current year|Earnings per share growth rate in current year Verona Pharma Inc. VRNA|Earnings per share growth in current year Jyong Biotech Ltd (MENS)|LGND (ligand.com) - Earnings per share increase in current year|Earnings per share growth in current year Amneal AMRX|Net earnings per share change in current year Perrigo Company PLC|ALVO: Net earnings per share growth this year|LQDA - Earnings growth in current year|GLPG: Earnings growth in current year|anipharmaceuticals.com (ANIP) - Earnings growth in current year|Earnings per share growth in current year MannKind|Earnings per share growth this year AMPH (Amphastar Pharmaceuticals Inc)|Net earnings per share growth this year PCRX (Pacira)|Net earnings per one share growth for the current year SPRY|Theravance Biopharma - Net earnings per share growth this year|Earnings growth in current year aquestive.com AQST|SCPH - Earnings per share growth in current year|Tectonic Therapeutic, Inc. (TECX) - Net earnings per share growth this year|TNXP (Tonix Pharmaceuticals Inc.) - Net earnings per share growth this year|China SXT Pharmaceuticals, Inc. - Earnings per share increase in current year|EPRX (Eupraxia Pharmaceuticals, Inc.) - Earnings growth in current year|Earnings per share growth in current year BHST|Earnings growth in current year EXOZ|Expected net earnings per share growth this year oramed.com|Earnings per share growth in current year Entera Bio ENTX|MindWalk Therapeutics (HYFT) - Earnings per share growth rate in current year|ABVC - Earnings per share growth in current year|Earnings per share trend in current year CPIX|FGEN: Earnings growth in current year|Telomir Pharmaceuticals Inc - Earnings per share increase in current year|RANI (Rani Therapeutics Holdings) - Earnings growth in current year|Earnings growth in current year Synergy CHC Corporation|Earnings per share growth in current year Rallybio Corporation (RLYB)|LEXX (lexariabioscience.com) - Earnings per share increase in current year|Earnings per share growth in current year Pulmatrix PULM|PTHL - Net earnings per share growth this year|Aptorum - Earnings growth in current year|LYRA - Earnings growth in current year|IBO (Impact BioMedical) - Net earnings per share growth this year|TNF Pharmaceuticals, Inc. - Earnings per share increase in current year|Earnings per share growth in current year cbdMD Inc.|Earnings per share growth in current year PRFX|Net earnings per share growth this year CYTO (Altamira Therapeutics)|Net earnings per one share growth for the current year LIPO|Earnings growth in current year OPTN (OptiNose, Inc.)|PIRS: Earnings per share growth this year|PROC - Earnings per share growth in current year|Net earnings per share change in current year Petros Pharmaceuticals Inc (PTPI)|Qilian International Holding Group Limited (QLI) - Earnings per share growth in current year|Earnings per share growth this year SLRN|Net earnings per share growth this year TFFP
